StopDown
Funding · 16 September 2026TRUE ARTIS₹11.4 Craesthetic surgery platformtrueartis.com ↗

TRUE ARTIS raises ₹11.4 Cr seed funding led by Zeropearl VC

By · Editor ·

seedDelhiFounded 2025
  • TRUE ARTIS is an aesthetic surgery platform operating in Delhi NCR with two centres and plans to open two more in the next six to eight months
  • The seed funding of ₹11.4 Cr is led by Zeropearl VC and includes participation from Eleven, Arjun Vaidya, Dr
  • Dhruv Joshi, Ambarish Gupta, and Vivek Lohcheb; the company has served over 10,000 clients and completed over 400 surgeries in the past nine months, with…

What happened

  • TRUE ARTIS raised ₹11.4 crore in a seed funding round led by Zeropearl VC.
  • The round also included participation from Eleven, a diversified business group of Medanta co-founder Sunil Sachdeva, and a group of angel investors.
  • The funding will be used to open two new centres in Delhi NCR over the next six to eight months.
  • The company plans to strengthen its surgical and recovery capabilities, expand its network of plastic and aesthetic surgeons, and develop its technology and patient-care systems.
  • TRUE ARTIS currently operates two centres in Delhi and Gurgaon, offering procedures across facial aesthetics, breast surgery, body contouring, and hair restoration.

Why it matters

  • The Indian aesthetic healthcare market is at an inflection point, with consumers placing greater emphasis on outcomes, safety, transparency, and experience.
  • TRUE ARTIS aims to build a new category in aesthetic healthcare by integrating clinical care, patient safety, and experience into its operating model.
  • The company is seeing demand from international patients and sees medical tourism as a potential area for future growth.

The business

  • TRUE ARTIS operates purpose-built aesthetic surgery centres where procedures are performed on-site.
  • Its facilities include operating theatres, surgical and medical equipment, dedicated recovery areas, ICU backup, and private patient suites.
  • The company works with a network of full-time and visiting plastic surgeons, allowing patients to consult specialists across different procedures through the same platform.
  • TRUE ARTIS has developed an in-house technology system to manage its operations and the patient journey, from initial enquiries and consultations to surgery and post-operative recovery.
  • The company has served more than 10,000 clients and completed over 400 surgeries in the past nine months.

The founders

Ankit Joshi

co-founder
  • Founded TRUE ARTIS in 2025.
  • Led the company's expansion plans and emphasized the importance of building a new category in aesthetic healthcare.

Sandeep Upadhyay

co-founder
  • Founded TRUE ARTIS in 2025.
  • Focused on creating a trusted aesthetic healthcare platform with clinical excellence, patient safety, and experience.

Who put in money

  • Zeropearl VC lead — A venture capital firm focused on early-stage investments in healthcare and technology.
  • Eleven investor — A diversified business group founded by Medanta co-founder Sunil Sachdeva.
  • Arjun Vaidya investor — Co-founder and investment partner at V3 Ventures.
  • Dr. Dhruv Joshi investor — Co-founder of Cloud Physician.
  • Ambarish Gupta investor — Founder and CEO of Basis Vectors Capital.
  • Vivek Lohcheb investor — CBO at PhonePe.

In numbers

10,000+clients served · 2026
400+surgeries completed · 2026
first centreEBITDA break-even · 2026
double-digit month-on-monthrevenue growth · 2026

What happens next

  • TRUE ARTIS plans to open two new centres in Delhi NCR over the next six to eight months.
  • The company will invest in strengthening its surgical and recovery capabilities, expanding its network of plastic and aesthetic surgeons, and developing its technology and patient-care systems.
  • TRUE ARTIS aims to consolidate its presence in Delhi NCR before expanding into other markets.

Earlier rounds

  • 2026-09-16 · seed · ₹11.4 Cr · led by Zeropearl VC

Up against

multispecialty hospitalsstandalone cosmetic clinics

In their words

“This investment is an important milestone for TRUE ARTIS, but its significance for us goes beyond the capital.”Ankit Joshi and Sandeep Upadhyay, co-founders
“We believe the Indian aesthetic healthcare market is at an inflection point.”Bipin Shah, Zeropearl VC

Words to know

EBITDA break-even
a financial term indicating that a company's operating revenues equal its operating expenses before interest, taxes, and non-cash charges.
aesthetic surgery
surgical procedures aimed at enhancing or altering a person's physical appearance.
plastic surgery
a type of surgery that involves the reconstruction or alteration of the human body, often for cosmetic or reconstructive purposes.
medical tourism
the practice of traveling to another country to receive medical treatment, often for reasons of cost, availability, or quality of care.

The numbers around it

Healthcare & Life Sciences in September 2026: 11 rounds with a disclosed amount, $114 million in all; the biggest was Ultrahuman ($70 mn). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Seed round: Pre-seed and seed are the first money a startup raises from outside investors. The difference is how much has been built when the cheque arrives: pre-seed backs an idea or prototype, usually with a cheque under ₹5 crore, while seed backs an early product and runs from a few crore rupees to a few million dollars.
  • Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.

All startup news on 16 September 2026 →

Is this TRUE ARTIS? Get your “Featured on StopDown” badge →